Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 4, 2003, Pages 1663-1672

  Narfström, Kristina ^a   Katz, Martin L ^b   Bragadottir, Ragnheidur ^c   Seeliger, Mathias ^d   Boulanger, Ana ^e   Redmond, T Michael ^e   Caro, Lynette ^a   Lai, Chooi May ^f   Rakoczy, P Elizabeth ^f  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e NATIONAL EYE INSTITUTE   (United States)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GREEN FLUORESCENT PROTEIN; PROTEIN AAV.RPE 65; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; BLINDNESS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOG; ELECTRORETINOGRAM; FLUORESCENCE MICROSCOPY; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENE TRANSFER; IMMUNOCYTOCHEMISTRY; NONHUMAN; NULL ALLELE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RPE65 GENE; UVEITIS; VISION;

ANIMALS; DARK ADAPTATION; DEPENDOVIRUS; DOG DISEASES; DOGS; ELECTRORETINOGRAPHY; EYE PROTEINS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LIPID METABOLISM; LUMINESCENT PROTEINS; MALE; MUTATION; NIGHT BLINDNESS; PIGMENT EPITHELIUM OF EYE; PROTEINS; RETINA; RETINAL DEGENERATION; UVEITIS; VISION TESTS;

EID: 0037379354     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0595     Document Type: Article

References (22)

1. Hamel CP, Tsilou E, Harris E, et al. A developmentally regulated microsomal protein specific for the pigment epithelium of the vertebrate retina. J Neurosci Res. 1993;34:414-425.
2. Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem. 1993;268:15751-15757.
3. Redmond TM, Yu S, Lee E, et al. RPE65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20: 344-351.
4. Seeliger MW, Grimm C, Stahlberg F, et al. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber Congenital amaurosis. Nat Genet. 2001;29:70-74.
5. Gu S-G, Thompson DA, Srikumari CRS, et al. Mutations in the RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet. 1997;17:194-197.
6. Marhlens F, Bareil C, Griffoin J-M, et al. Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet. 1997;17:139-141.
7. Morimura H, Fishman GA, Grover SA, et al. Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or Leber congenital amaurosis. Proc Natl Acad Sci 1998;95:3088-3093.
8. Thompson DA, Gyurus P, Fleischer LL, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41:4293-4299.
9. Narfstrom K, Wrigstad A, Nilsson SEG. The Briard dog: a new animal model of congenital stationary night blindness. Br J Ophthalmol. 1989;73:750-756.
10. Narfström K, Wrigstad A, Ekesten B, Nilsson SE. Hereditary retinal dystrophy in the Briard dog: clinical and hereditary characteristics. Prog Vet Comp Ophthalmol. 1994;4:85-92.
11. Wrigstad A, Nilsson, SEG, Narfström K. Ultrastructuval changes of the retina in Briard dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res. 1992;55:805-818.
12. Veske A, Nilsson, SEG, Narfstrom K, Gal A. Retinal dystrophy of Swedish Briard/Beagle dogs is due to a 4-bp deletion in RPE65. Genomics. 1999;57:57-61.
13. Aguirre G, Baldwin V, Pearce-Kelling S, et al. Congenital stationary night blindness in the dog: common mutation in the RPE65 gene indicates founder effect. Mol Vis. 1998;4:23.
14. Wrigstad A. Hereditary dystrophy of the retina and the retinal pigment epithelium in a strain of Briard dogs: a clinical, morphological and electrophysiological study. Linkoping Univ Med Dissertations. 1994;423:1-116.
15. Wrigstad A, Narfstrom K, Nilsson SEG. Slowly progressive changes of the retina and the retinal pigment epithelium in Briard dogs with hereditary retinal dystrophy: a morphological study. Doc Ophthalmol. 1994;87:337-354.
16. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
17. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol. 1989;63:3822-3828.
18. Skulimowski AW, Samulski RJ. Adeno-associated virus: integrating vectors for human gene therapy. Methods Mol Genet. 1995;7:3-12.
19. Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 1999;6:973-985.
20. Saari JC. The sights along route 65. Nat Genet. 2001;29:8-9.
21. Geri I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. In: Osborne N, Chader, G, eds. Progress in Retinal Research. Oxford, UK: Pergamon Press; 1986;75-109.
22. Ham D-I, Gentleman S, Chan C-C, McDowell JH, Redmond TM, Gery I. RPE65 is highly uveitogenic in rats. Invest Ophthalmol Vis Sci. 2002;43:2258-2263.